{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:23:23Z","timestamp":1774063403901,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1053\/j.ackd.2013.06.010","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T14:55:08Z","timestamp":1387551308000},"page":"56-63","source":"Crossref","is-referenced-by-count":27,"title":["Tubulointerstitial Injury Associated With Chemotherapeutic Agents"],"prefix":"10.1053","volume":"21","author":[{"given":"Anushree C.","family":"Shirali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ackd.2013.06.010_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.pharmtox.44.101802.121856","article-title":"Transporters and renal drug elimination","volume":"44","author":"Lee","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"10.1053\/j.ackd.2013.06.010_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2013.06.010_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/tpj.2009.45","article-title":"Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients","volume":"10","author":"Khrunin","year":"2010","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1053\/j.ackd.2013.06.010_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.1980.181","article-title":"Metabolism of drugs by the kidney","volume":"18","author":"Anders","year":"1980","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib5","first-page":"229","article-title":"The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited","volume":"19","author":"Betjes","year":"2006","journal-title":"J Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.1999.5680","article-title":"Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature","volume":"76","author":"Wong","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1053\/j.ackd.2013.06.010_bib7","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: a systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2013.06.010_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2013.06.010_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1, -\u03b2, or -\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2013.06.010_bib11","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1053\/j.ackd.2013.06.010_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib13","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1053\/j.ackd.2013.06.010_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1023\/A:1008213732429","article-title":"Oxaliplatin: a review of preclinical and clinical studies","volume":"9","author":"Raymond","year":"1998","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.ackd.2013.06.010_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1523-1755.2004.00720.x","article-title":"Nephrotoxicity of platinum complexes is related to basolateral organic cation transport","volume":"66","author":"Ludwig","year":"2004","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2013.06.010_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00467-004-1807-3","article-title":"Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity","volume":"20","author":"Aleksa","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MPH.0b013e3181f8cac0","article-title":"Nephrotoxicity\u2013what do we know and what don't we know?","volume":"33","author":"Skinner","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention\/therapy","volume":"30","author":"Perazella","year":"2010","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2013.06.010_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/j.ajkd.2011.04.030","article-title":"Kidney tubular toxicity of maintenance pemetrexed therapy","volume":"58","author":"Glezerman","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MPH.0b013e3181f8cac0","article-title":"Nephrotoxicity\u2014what do we know and what don't we know?","volume":"33","author":"Skinner","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ajkd.2007.10.039","article-title":"Partial Fanconi syndrome induced by imatinib therapy: A novel cause of urinary phosphate loss","volume":"51","author":"Fran\u00e7ois","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2013.06.010_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-108-1-21","article-title":"Renal salt wasting in patients treated with cisplatin","volume":"108","author":"Hutchison","year":"1988","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3816\/CCC.2006.n.033","article-title":"Cetuximab-induced hypomagnesemia in patients with colorectal cancer","volume":"6","author":"Fakih","year":"2006","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"10.1053\/j.ackd.2013.06.010_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","article-title":"Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: A prospective study","volume":"8","author":"Tejpar","year":"2007","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2013.06.010_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2005.01.008","article-title":"Causes of reversible nephrogenic diabetes insipidus: a systematic review","volume":"45","author":"Garofeanu","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"issue":"10","key":"10.1053\/j.ackd.2013.06.010_bib28","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.20255","article-title":"High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma","volume":"100","author":"Widemann","year":"2004","journal-title":"Cancer"},{"issue":"25","key":"10.1053\/j.ackd.2013.06.010_bib29","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2009.25.4540","article-title":"Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome","volume":"28","author":"Widemann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2013.06.010_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ndtplus\/sfp048","article-title":"Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis","volume":"2","author":"Jolly","year":"2009","journal-title":"NDT Plus"},{"issue":"2","key":"10.1053\/j.ackd.2013.06.010_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMc0904283","article-title":"Anti-CTLA4 Antibody\u2013Induced lupus nephritis","volume":"361","author":"Fadel","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.ackd.2013.06.010_bib32","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.ackd.2013.06.010_bib33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/1097-0142(19810915)48:6<1328::AID-CNCR2820480613>3.0.CO;2-N","article-title":"Nephrotoxicity of nitrosoureas","volume":"48","author":"Schacht","year":"1981","journal-title":"Cancer"},{"issue":"8","key":"10.1053\/j.ackd.2013.06.010_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrneph.2009.97","article-title":"Chemotherapy-associated renal dysfunction","volume":"5","author":"Sahni","year":"2009","journal-title":"Nat Rev Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154855951300092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154855951300092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T10:32:48Z","timestamp":1647772368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154855951300092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S154855951300092X"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2013.06.010","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}